Atomoxetine
آتوموکستین
🧠 Nervous SystemSelective norepinephrine reuptake inhibitor (non-stimulant)
Market / country: 🇺🇸 USA
Strattera (US)
🧮 Dose calculator
Attention-deficit/hyperactivity disorder · Regimen source: FDA Atomoxetine · 2.3 (Highlights dosage table)
- • Target 1.2 mg/kg/day; max 1.4 mg/kg/day or 100 mg, whichever is less. Once in the morning or two equal doses. Do not open capsules. FDA Atomoxetine · 2.3 (Highlights dosage table)FDA Atomoxetine · 2.2
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ MAOI within 14 days; narrow-angle glaucoma; hypersensitivity. FDA Atomoxetine · 4
Warnings
- • Boxed warning: suicidal thoughts and behaviors in pediatric patients ≥6 years; monitor closely. Screen for bipolar history before starting. FDA Atomoxetine · WARNING: SUICIDAL THOUGHTS AND BEHAVIORS IN PEDIATRIC PATIENTSFDA Atomoxetine · 2.1
Formulations
- 10 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 18 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 25 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 40 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 60 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 80 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 100 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Atomoxetine · 8.1
“Risk Summary Available published studies with atomoxetine use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Atomoxetine · 8.2
“Risk Summary There are no data on the presence of atomoxetine or its metabolite in human milk, the effects on the breastfed child, or the effects on milk production.”
- 👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Atomoxetine · Boxed Warning
“• All atomoxetine-treated pediatric patients 6 years of age or older should be monitored and observed closely for suicidal thoughts and behavior, clinical worsening, or unusual changes in behavior, especially during the initial months of therapy or at times of dosage changes.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Atomoxetine · 8.5
“The safety, efficacy and pharmacokinetics of atomoxetine in geriatric patients have not been evaluated.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA079019
- DailyMed (FDA label)FDA Atomoxetine
- MedlinePlus (NIH)Atomoxetine
- WHO ATC/DDDN06BA09
- Darooyab (Iran)Atomoxetine
🇮🇷 Registered in Iran Darooyab · G-3367/Atomoxetine
Dosage forms with Iranian generic codes, per Darooyab.
- 08394 · ATOMOXETINE 10MG CAP · کپسول اتوموکستین ۱۰ میلیگرم
- 16730 · ATOMOXETINE 10MG TAB · قرص اتوموکستین ۱۰ میلیگرم
- 06135 · ATOMOXETINE 18MG CAP · کپسول اتوموکستین ۱۸ میلیگرم
- 16731 · ATOMOXETINE 18MG TAB · قرص اتوموکستین ۱۸ میلیگرم
- 06136 · ATOMOXETINE 25MG CAP · کپسول اتوموکستین ۲۵ میلیگرم
- 16732 · ATOMOXETINE 25MG TAB · قرص اتوموکستین ۲۵ میلیگرم
- 06134 · ATOMOXETINE 40MG CAP · کپسول اتوموکستین ۴۰ میلیگرم
- 17843 · ATOMOXETINE 40MG TAB · قرص اتوموکستین ۴۰ میلیگرم
- 07287 · ATOMOXETINE 60MG CAP · کپسول اتوموکستین ۶۰ میلیگرم
- 17844 · ATOMOXETINE 60MG TAB · قرص اتوموکستین ۶۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Atomoxetine · 3FDA Atomoxetine · 2.3 (Highlights dosage table)FDA Atomoxetine · 2.2FDA Atomoxetine · 4FDA Atomoxetine · WARNING: SUICIDAL THOUGHTS AND BEHAVIORS IN PEDIATRIC PATIENTSFDA Atomoxetine · 2.1FDA Atomoxetine · 8.1FDA Atomoxetine · 8.2FDA Atomoxetine · Boxed WarningFDA Atomoxetine · 8.5FDA Atomoxetine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3367/Atomoxetine
- Clinical review⚠ Unverified